1. Home
  2. EQT vs BNTX Comparison

EQT vs BNTX Comparison

Compare EQT & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EQT
  • BNTX
  • Stock Information
  • Founded
  • EQT 1925
  • BNTX 2008
  • Country
  • EQT United States
  • BNTX Germany
  • Employees
  • EQT N/A
  • BNTX N/A
  • Industry
  • EQT Oil & Gas Production
  • BNTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EQT Energy
  • BNTX Health Care
  • Exchange
  • EQT Nasdaq
  • BNTX Nasdaq
  • Market Cap
  • EQT 20.4B
  • BNTX 23.9B
  • IPO Year
  • EQT N/A
  • BNTX 2019
  • Fundamental
  • Price
  • EQT $50.98
  • BNTX $98.76
  • Analyst Decision
  • EQT Buy
  • BNTX Strong Buy
  • Analyst Count
  • EQT 18
  • BNTX 17
  • Target Price
  • EQT $55.82
  • BNTX $145.88
  • AVG Volume (30 Days)
  • EQT 9.2M
  • BNTX 1.1M
  • Earning Date
  • EQT 04-22-2025
  • BNTX 05-05-2025
  • Dividend Yield
  • EQT 1.24%
  • BNTX N/A
  • EPS Growth
  • EQT N/A
  • BNTX N/A
  • EPS
  • EQT 0.45
  • BNTX N/A
  • Revenue
  • EQT $5,041,956,000.00
  • BNTX $2,848,224,455.00
  • Revenue This Year
  • EQT $64.92
  • BNTX N/A
  • Revenue Next Year
  • EQT $11.46
  • BNTX $9.21
  • P/E Ratio
  • EQT $113.73
  • BNTX N/A
  • Revenue Growth
  • EQT 1.36
  • BNTX N/A
  • 52 Week Low
  • EQT $30.02
  • BNTX $76.53
  • 52 Week High
  • EQT $56.66
  • BNTX $131.49
  • Technical
  • Relative Strength Index (RSI)
  • EQT 51.10
  • BNTX 51.52
  • Support Level
  • EQT $49.57
  • BNTX $83.59
  • Resistance Level
  • EQT $51.94
  • BNTX $103.59
  • Average True Range (ATR)
  • EQT 2.78
  • BNTX 5.40
  • MACD
  • EQT -0.02
  • BNTX 1.64
  • Stochastic Oscillator
  • EQT 63.44
  • BNTX 78.43

About EQT EQT Corporation

EQT Corp is an independent natural gas production company with operations focused in the cores of the Marcellus and Utica shales in the Appalachian Basin, located in the Eastern United States. The firm focuses on executing combo-development projects for developing multiwell pads to meet supply needs, with a focus on maximizing operational efficiency, technology, and sustainability. Its main customers include marketers, utilities, and industrial operators in the Appalachian Basin. The company has one reportable segment and its revenue stems from three types of gas reserves: natural gas, natural gas liquids, and crude oil. All of the firm's operating revenue is generated in the U.S., with most revenue flowing from the Marcellus Shale field and through the sale of natural gas.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

Share on Social Networks: